Burden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population

Hanane Khoury1, Isla Ogilvie, Antoine C El Khoury

  • 1BioMedCom Consultants inc,, 1405 TransCanada Highway, Suite 310, Montreal, Quebec H9P 2V9, Canada. hanane_khoury@biomedcom.org

BMC Infectious Diseases
|January 11, 2011
PubMed

Insights

Rotavirus gastroenteritis (RVGE) significantly impacts children under five in the Middle East and North Africa, causing high hospitalization and mortality rates. A broad-coverage rotavirus vaccine is crucial to reduce this disease burden.

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Rotavirus gastroenteritis (RVGE) is a leading cause of severe diarrhea in children globally.
  • Estimating the RVGE burden in children under five is critical for public health interventions in the Middle East, North Africa, and Turkey.

Purpose of the Study:

  • To estimate the burden of rotavirus gastroenteritis (RVGE) in children under five years old across the Middle East, North Africa, and Turkey.
  • To analyze the epidemiological characteristics and economic impact of RVGE in the specified regions.

Main Methods:

  • A systematic literature search was performed for studies published between 1999 and 2009.
  • Data on RVGE epidemiology, burden, and rotavirus genotypes were extracted and compared across countries.

Main Results:

  • 43 studies were identified, showing RVGE prevalence in 16-61% of acute gastroenteritis cases, peaking in winter.
  • RVGE-related hospitalizations ranged from 14% to 45%, with annual fatalities up to 112 per 100,000 in some areas.
  • Significant economic burden was noted, with hospitalization costs between $1.8-$4.6 million annually; G1P[8] and G2P[4] were prevalent genotypes.

Conclusions:

  • RVGE poses a substantial morbidity, mortality, and economic challenge in the studied regions.
  • The diversity of rotavirus strains necessitates a vaccine with broad and consistent serotype coverage.
  • Vaccination strategies are essential to mitigate the RVGE burden in the Middle East and North Africa.
Abstract

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...